Closed
SectorHealthcare
47.81 0.57
24h
Min
46.89
Max
49.62
Income | 5.2M -66M |
---|---|
Sales | 15M 22M |
EPS | -0.82 |
Profit margin | -296.747 |
Employees | 208 |
EBITDA | -5.7M -74M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +26.94% upside |
Next Earnings | 7 sie 2025 |
---|
Market Cap | 622M 2.8B |
---|---|
Previous open | 47.24 |
Previous close | 47.81 |
By Acuity
34%
66%
95 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 60.5 USD 26.94%
High 79 USD
Low 51 USD
Based on 15 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$